News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
855,179 Results
Type
Article (87041)
Company Profile (704)
Press Release (767421)
Multimedia
Podcasts (154)
Webinars (20)
Section
Business (232900)
Career Advice (4133)
Deals (39770)
Drug Delivery (131)
Drug Development (91146)
Employer Resources (200)
FDA (18214)
Job Trends (17374)
News (397009)
Policy (39854)
Tag
Academia (3002)
Academic (2)
Accelerated approval (15)
Adcomms (33)
Allergies (110)
Alliances (56978)
ALS (123)
Alzheimer's disease (1618)
Antibody-drug conjugate (ADC) (192)
Approvals (18177)
Artificial intelligence (420)
Autoimmune disease (39)
Automation (22)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (139)
Biotechnology (482)
Bladder cancer (109)
Brain cancer (44)
Breast cancer (412)
Cancer (3272)
Cardiovascular disease (263)
Career advice (3542)
Career pathing (34)
CAR-T (217)
CDC (43)
Cell therapy (599)
Cervical cancer (25)
Clinical research (74566)
Collaboration (1172)
Company closure (3)
Compensation (782)
Complete response letters (42)
COVID-19 (2917)
CRISPR (71)
C-suite (409)
Cystic fibrosis (125)
Data (3338)
Decentralized trials (2)
Denatured (55)
Depression (84)
Diabetes (390)
Diagnostics (7009)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (195)
Drug pricing (160)
Drug shortages (36)
Duchenne muscular dystrophy (167)
Earnings (98296)
Editorial (50)
Employer branding (25)
Employer resources (169)
Events (131721)
Executive appointments (931)
FDA (20241)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1052)
Gene editing (154)
Generative AI (42)
Gene therapy (470)
GLP-1 (959)
Government (5301)
Grass and pollen (7)
Guidances (312)
Healthcare (20921)
HIV (47)
Huntington's disease (32)
IgA nephropathy (48)
Immunology and inflammation (198)
Immuno-oncology (15)
Indications (43)
Infectious disease (3124)
Inflammatory bowel disease (168)
Inflation Reduction Act (13)
Influenza (80)
Intellectual property (135)
Interviews (813)
IPO (17908)
IRA (58)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (63)
Layoffs (608)
Leadership (27)
Legal (10139)
Liver cancer (87)
Longevity (12)
Lung cancer (455)
Lymphoma (230)
Machine learning (16)
Management (65)
Manufacturing (494)
MASH (106)
Medical device (14766)
Medtech (14776)
Mergers & acquisitions (22632)
Metabolic disorders (996)
Multiple sclerosis (107)
NASH (23)
Neurodegenerative disease (166)
Neuropsychiatric disorders (48)
Neuroscience (2429)
NextGen: Class of 2025 (7687)
Non-profit (5091)
Now hiring (51)
Obesity (505)
Opinion (296)
Ovarian cancer (108)
Pain (132)
Pancreatic cancer (136)
Parkinson's disease (207)
Partnered (26)
Patents (348)
Patient recruitment (200)
Peanut (55)
People (65850)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23001)
Phase II (32371)
Phase III (24386)
Pipeline (2069)
Policy (260)
Postmarket research (3554)
Preclinical (10391)
Press Release (72)
Prostate cancer (159)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (551)
Real estate (7402)
Recruiting (76)
Regulatory (27390)
Reports (63)
Research institute (2667)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (13)
RSV (62)
Schizophrenia (110)
Series A (175)
Series B (125)
Service/supplier (30)
Sickle cell disease (69)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4309)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (75)
The Weekly (97)
Vaccines (953)
Venture capital (62)
Weight loss (343)
Women's health (53)
Worklife (20)
Date
Today (160)
Last 7 days (819)
Last 30 days (2464)
Last 365 days (33884)
2025 (20718)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (73)
Alaska (7)
Arizona (283)
Arkansas (14)
Asia (50633)
Australia (8896)
California (8278)
Canada (2528)
China (759)
Colorado (353)
Connecticut (369)
Delaware (222)
Europe (116244)
Florida (1237)
Georgia (280)
Hawaii (3)
Idaho (67)
Illinois (764)
India (35)
Indiana (406)
Iowa (19)
Japan (250)
Kansas (118)
Kentucky (34)
Louisiana (20)
Maine (74)
Maryland (1161)
Massachusetts (6314)
Michigan (283)
Minnesota (516)
Mississippi (4)
Missouri (109)
Montana (32)
Nebraska (26)
Nevada (89)
New Hampshire (74)
New Jersey (2302)
New Mexico (31)
New York (2283)
North Carolina (1292)
North Dakota (10)
Northern California (3617)
Ohio (265)
Oklahoma (17)
Oregon (48)
Pennsylvania (1764)
Puerto Rico (18)
Rhode Island (41)
South America (1654)
South Carolina (38)
South Dakota (1)
Southern California (3105)
Tennessee (135)
Texas (1266)
United States (31044)
Utah (241)
Virginia (224)
Washington D.C. (80)
Washington State (719)
West Virginia (4)
Wisconsin (89)
There are 855,179 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
C-suite
Caught In Sarepta ‘Downdraft,’ Arrowhead Becomes RNAi Knight in Shining Armor
Sarepta’s troubles had nothing to do with Arrowhead’s assets, and yet both companies have seen their stock prices decline this past month.
BioSpace
caught up with Arrowhead’s Chris Anzalone to talk about the biotech’s role as an RNAi pipeline savior.
August 12, 2025
·
7 min read
·
Annalee Armstrong
Layoff Tracker
Merck To Cut 58 People at Rahway HQ
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
August 12, 2025
·
182 min read
·
BioSpace Editorial Staff
Cancer
Bayer Makes Potential $1.3B Cancer Bet in Kumquat Deal
For $1.3 billion in aggregate—including upfront and milestone payments—Bayer will get exclusive global access to Kumquat Biosciences’ small-molecule KRAS G12D blocker.
August 12, 2025
·
2 min read
·
Tristan Manalac
Vaccines
HHS Freezes Vaxart’s Oral COVID-19 Vaccine, Again
The stop order came on Aug. 5, the same day Health Secretary Robert F. Kennedy Jr. terminated 22 mRNA vaccine projects under the Biomedical Advanced Research and Development Authority, though Vaxart’s candidate is protein-based.
August 12, 2025
·
2 min read
·
Tristan Manalac
Government
Medical Journal Refuses to Retract Vaccine Study Despite RFK Jr.’s Criticism
The
Annals of Internal Medicine
ran a large-scale study in July, pointing to the lack of an association between childhood aluminum exposure through vaccination and chronic conditions. The Health Secretary, in an opinion piece earlier this month, called the paper a “ballyhooed study.”
August 12, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Xspray Pharma Signs License Agreement with Handa Therapeutics – to Receive up to Double-Digit Royalty on Handa’s Net Proceeds
August 12, 2025
·
1 min read
Press Releases
PureTech Announces the Launch of Celea Therapeutics With a Mission to Transform the Treatment of Respiratory Diseases
August 12, 2025
·
8 min read
Press Releases
Newron Begins Enrollment in Pivotal Phase III ENIGMA-TRS Program With Evenamide as Add-on Therapy in Patients With Treatment-Resistant Schizophrenia (TRS)
August 12, 2025
·
9 min read
Press Releases
Bruker Announces Quarterly Dividend - August 12, 2025
August 12, 2025
·
2 min read
Press Releases
AN2 Therapeutics Commences First-in-Human Clinical Trial of Oral AN2-502998 for Chagas Disease
August 12, 2025
·
5 min read
1 of 85,518
Next
